Although routine clinical markers are used routinely to determine the stage of human immunodeficiency virus (HIV) disease, their use in monitoring response to antiretroviral therapy is poorly defined. Selected clinical markers were evaluated for their ability to predict first‐line antiretroviral therapy success. No clinically meaningful variables were identified that predicted virologic or immunological success, implying that the CD4+ cell count and HIV type 1 RNA level data are required for optimal management of antiretroviral therapy.
Cited by
Yoann Madec, Elisabeth Szumilin, Christine Genevier, Laurent Ferradini, Suna Balkan, Mar Pujades, Arnaud Fontanet. (2009) Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries.
AIDS 27:7, 853-861
Online publication date: 1-May-2009.
CrossRef Paul Collini, Uli Schwab, Stephen Sarfo, Joseph Obeng‐Baah, Betty Norman, David Chadwick, David Bibby, and George Bedu‐Addo. (2009) Sustained Immunological Responses to Highly Active Antiretroviral Therapy at 36 Months in a Ghanaian HIV Cohort.
Clinical Infectious Diseases 48:7, 988-991
Online publication date: 1-Apr-2009.
Alexandra Calmy, Cecilia Pizzocolo, Louis Pizarro, Gilles Brücker, Robert Murphy, Christine Katlama. (2008) The marriage of science and optimized HIV care in resource-limited settings.
AIDS 22:17, 2227-2230
Online publication date: 1-Dec-2008.
CrossRef Sydney Rosen, Lawrence Long, Ian Sanne. (2008) The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.
Tropical Medicine & International Health 13:8, 1005-1015
Online publication date: 1-Sep-2008.
CrossRef Fred Lutwama, Ronnie Serwadda, Harriet Mayanja-Kizza, Hasan M Shihab, Allan Ronald, Moses R Kamya, David Thomas, Elizabeth Johnson, Thomas C Quinn, Richard D Moore, Lisa A Spacek. (2008) Evaluation of Dynabeads and Cytospheres Compared With Flow Cytometry to Enumerate CD4+ T Cells in HIV-Infected Ugandans on Antiretroviral Therapy.
JAIDS Journal of Acquired Immune Deficiency Syndromes 48:3, 297-303
Online publication date: 1-Aug-2008.
CrossRef Davey M. Smith and Robert T. Schooley. (2008)
Editorial Commentary: Running with Scissors: Using Antiretroviral Therapy without Monitoring Viral Load.
Clinical Infectious Diseases 46:10, 1598-1600
Online publication date: 15-May-2008.
Fran??ois Rouet, Marie-Laure Chaix, Eric Nerrienet, Nicole Ngo-Giang-Huong, Jean-Christophe Plantier, Marianne Burgard, Martine Peeters, Florence Damond, Didier Koumavi Ekouevi, Philippe Msellati, Laurent Ferradini, Sandra Rukobo, Val??rie Mar??chal, Nilda Schvachsa, Lahcen Wakrim, Christian Rafalimanana, Benjamin Rakotoambinina, Jean-Paul Viard, Jean-Marie Seigneurin, Christine Rouzioux. (2007) Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification.
JAIDS Journal of Acquired Immune Deficiency Syndromes 45:4, 380-388
Online publication date: 1-Sep-2007.
CrossRef Gary M Cohen. (2007) Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries.
AIDS 21:Suppl 4, S81-S87
Online publication date: 1-Aug-2007.
CrossRef Robert T. Schooley. (2007)
Editorial Commentary: Viral Load Testing in Resource‐Limited Settings.
Clinical Infectious Diseases 44:1, 139-140
Online publication date: 1-Jan-2007.
Anna K. Person, Habib O. Ramadhani, Nathan M. Thielman. (2007) Antiretroviral treatment strategies in resource-limited settings.
Current HIV/AIDS Reports 4:2, 73
CrossRef